Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PlaSenTer: Convalescent Plasma for COVID-19
NCT04873414Phase 3Unknown
- Start
- Dec 2020
- Primary completion
- Oct 2021
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in coronavirus disease 2019 (COVID-19). Status: unknown.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04873414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04873414.